France· FR:63967296
TRAVOPROST/TIMOLOL EG 40 microgrammes/mL + 5 mg/mL, collyre en solution
A medicinal product containing maléate de timolol + travoprost, registered in France by EG LABO - LABORATOIRES EUROGENERICS, on the national reimbursement list.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE TIMOLOL + TRAVOPROST
- Manufacturer
- EG LABO - LABORATOIRES EUROGENERICS
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip1334009301051841 flacon(s) polypropylène de 2,5 ml avec embout(s) en polyéthylène basse densité (PEBD) avec fermeture de sécuritéEUR 7.04
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Maléate de timolol + travoprost in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomDuoTrav 40micrograms/ml / 5mg/ml eye dropsWaymade Healthcare Plc
- CzechiaDUOTRAVNovartis Europharm Limited, Dublin
- GermanyJokathPharmathen S.A.
- NetherlandsDuoTrav 40 microgram/ml + 5 mg/ml oogdruppels, oplossingNovartis Europharm Limited
- ItalyALDUOVIZGENETIC S.P.A.
- SpainDIXANOR 40 MICROGRAMOS/ML + 5 MG/ML COLIRIO EN SOLUCIONLaboratorio Stada S.L.
- SwitzerlandDuotrav
- PolandDuoTravNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Kivizidiale, Syntragut
- Belgium · Filiop, Kivizidiale
- Bulgaria · Даверис-Т, Кивизидиал
- Cyprus · Kivizidiale, Tratim
- Czechia · Kivizidiale, Travoprost/Timolol Olikla
- Germany · Kivizidiale, Syntragut
- Denmark · Eltenodo, Filiop
- Estonia · Travoprost/Timolol Elvim, Travoprost/Timolol Viatris
- Spain · Filiop, Kivizidiale
- Finland · Travoprost/Timolol Stada, Trevicopto Comp
- United Kingdom (Northern Ireland) · Travoprost + Timolol Blumont Pharma, Travoprost/Timolol Aspire
- Greece · Eltenodo, Kivizidiale
- Croatia · Kivizidiale
- Hungary · Kivizidiale, Travoprost/Timolol Polpharma
- Iceland · Duotrav, Travoprost/Timolol Medical Valley
- Italy · Alduoviz, Enteglock
- Liechtenstein · Duotrav
- Lithuania · Travoprost/Timolol Elvim, Travoprost/Timolol Polpharma
- Luxembourg · Filiop, Kivizidiale
- Latvia · Travoprost/Timolol Elvim, Travoprost/Timolol Polpharma
- Netherlands · Filiop, Kivizidiale
- Norway · Duotrav, Travabloc
- Poland · Kivizidiale, Rozaduo
- Portugal · Nexotrav, Syntragut
- Romania · Kivizidiale, Travoprost/Timolol Zentiva
- Sweden · Travabloc, Travoprost/Timolol Medical Valley
- Slovakia · Kivizidiale, Travoprost/Timolol Olikla
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/01997c35-31e9-4cc7-8364-2b3b2deb6c9f GET /v1/drugs/01997c35-31e9-4cc7-8364-2b3b2deb6c9f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "63967296",
"date_amm": "2017-07-17",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "MALÉATE DE TIMOLOL + TRAVOPROST",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "collyre en solution",
"voies_administration": "ophtalmique",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about maléate de timolol + travoprost.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.